Life Sciences & Pharma Royalty Financing Comes of Age: Why This Once-Niche Source of Capital Is Gaining Momentum April 17, 2026
Life Sciences & Pharma Modular Medicines: Combinatorial Modularity as a Strategic Source of Innovation April 14, 2026
Life Sciences & Pharma A Bifurcated Lab Market Is Reshaping Strategic Priorities and Capital Decisions February 27, 2026
MedTech Reinventing Value Creation in Medtech CDMO: A Smarter Playbook for PE Exits February 26, 2026